 Lung Neoplasms
"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
| Descriptor ID |
D008175
|
| MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
| Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 16 | 5 | 21 | | 1997 | 25 | 2 | 27 | | 1998 | 13 | 2 | 15 | | 1999 | 12 | 2 | 14 | | 2000 | 16 | 1 | 17 | | 2001 | 14 | 7 | 21 | | 2002 | 38 | 8 | 46 | | 2003 | 22 | 3 | 25 | | 2004 | 33 | 5 | 38 | | 2005 | 37 | 3 | 40 | | 2006 | 36 | 9 | 45 | | 2007 | 45 | 8 | 53 | | 2008 | 39 | 7 | 46 | | 2009 | 40 | 4 | 44 | | 2010 | 55 | 4 | 59 | | 2011 | 39 | 4 | 43 | | 2012 | 60 | 5 | 65 | | 2013 | 69 | 12 | 81 | | 2014 | 74 | 8 | 82 | | 2015 | 67 | 9 | 76 | | 2016 | 82 | 8 | 90 | | 2017 | 80 | 9 | 89 | | 2018 | 91 | 10 | 101 | | 2019 | 85 | 4 | 89 | | 2020 | 83 | 6 | 89 | | 2021 | 87 | 2 | 89 | | 2022 | 91 | 1 | 92 | | 2023 | 89 | 2 | 91 | | 2024 | 57 | 5 | 62 | | 2025 | 64 | 3 | 67 | | 2026 | 40 | 2 | 42 |
To return to the timeline, click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Florez N, Patel SP, Salgia R, Sands J, Schenk EL, Shum E, Aldea M, Bestvina CM, Donington J, Garcia CA, Nieva J, Gandara DR, Halmos B, Hirsch FR, Le X, Lee P, Malhotra J, Patil T, Peters S, Riess JW, Rotow J, Rous FA, Sabari J, Sen T, Singhi EK, Velázquez AI, Wakelee HA, Kim ES. Current challenges and emerging therapeutic strategies in lung cancer care: Insights from Bridging the Gaps 2025. Cancer. 2026 Oct 01; 132(19):e70633.
-
Sharma JR, Singh V, Kandhari K, Agraval H. From smoke to stemness: Mechanisms of cancer stem cell induction by cigarette smoke. Biochim Biophys Acta Rev Cancer. 2026 Oct; 1881(5):189700.
-
Le X, Passaro A, Zhao Y, Huang Y, Laskin J, Rodriguez-Abreu D, Calles A, Bazhenova L, Lo Russo G, Leighl NB, Cappuzzo F, Girard N, Popat S, Fang W, Luo Y, Li W, He Z, Zhao H, Li M, Song Q, Zhao H, El Darsa H, Monnet I, Cobo Dols M, García Campelo R, Jotte R, Berz D, Spira A, Pérol M, Nagasaka M, West H, Styles L, Li J, Clow F, Goldman J, Zhang L. Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 2026 Sep; 27(9):1094-1109.
-
Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Treece AL, Gratias EJ, Cost NG, Grundy PE, Fernandez CV, Dome JS, Geller JI. Feasibility of Real-Time Central Risk Assignment for Children's Oncology Group Pediatric Renal Tumor Trials. Pediatr Blood Cancer. 2026 Nov; 73(11):e70639.
-
Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Gratias EJ, Cost NG, Parsons LN, Grundy PE, Fernandez CV, Geller JI, Dome JS. Concordance Between Institutional and Central Pathology, Surgery, and Radiology Reviews on the Children's Oncology Group AREN03B2 Renal Tumor Biology and Classification Study. Pediatr Blood Cancer. 2026 Oct; 73(10):e70515.
-
Contreras-Zárate MJ, Jaramillo-Gómez JA, Marquez-Ortiz RA, Pham TC, Koliavas SN, Ormond DR, Navarro AC, Nemenoff RA, Camidge DR, Cittelly DM. Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain Metastases. Cancer Res Commun. 2026 Aug 01; 6(8):1850-1861.
-
Phillips WJ, Leong R, Yeung B, Al Lawati A, Camidge DR, Lo B, Wheatley-Price P. The Prognostic Significance of EGFR Adjusted Variant Allele Frequency on First-Line Osimertinib Efficacy in Advanced EGFR-Mutant NSCLC. Curr Oncol. 2026 Jul 23; 33(8).
-
Fox AH, Ward RC, Alexander M, Osarogiagbon RU, Smith RA, Studts JL, Silvestri GA. Rates of Systemic Treatment for Metastatic Non-Small Cell Lung Cancer Among Older Adults. JAMA Oncol. 2026 Jul 01; 12(7):705-713.
-
Gorbatov ML, Arizpe A, David EA, Liu L, Cockburn M, Farias AJ. Racial and ethnic disparities in receipt of guideline-concordant treatment for early-stage non-small cell lung cancer. Cancer Causes Control. 2026 Jul 01; 37(7).
-
Nightingale CL, Snavely AC, Levine BJ, Turner JC, Farris MK, Tingen MS, Foust M, Graves K, Danai J, Price SN, Asad SS, Adonizio CS, Lesser GJ, Childrey L, Weaver KE. Multi-site feasibility of a web-based and telephone navigation intervention to connect lung cancer caregivers in community oncology settings with resources: Protocol for the WF-2301CD Caregiver Oncology Needs Evaluation Tool (CONNECT) trial. Contemp Clin Trials. 2026 Sep; 168:108387.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|